{"product_id":"fgfr1alpha-antibody-sc-f2732","title":"FGFR1α Antibody","description":"\u003ch2\u003eAbout the Target\u003c\/h2\u003e\u003cp\u003eFGFR1ALPHA is a target of interest in many antibody-based workflows. The FGFR1 gene undergoes alternative RNA processing, resulting in the production of distinct receptor isoforms with different functional properties. This splicing generates two main forms: FGFR1α, which includes three immunoglobulin (Ig)-like extracellular domains, and FGFR1β, which contains only two. The difference arises from the inclusion (FGFR1α) or exclusion (FGFR1β) of the α-exon. Depending on the literature source, FGFR1ALPHA may also be discussed as Fibroblast growth factor receptor 1 and FGFR-1.\u003c\/p\u003e\u003cp\u003eReported cellular context includes cell membrane, cytoplasm, cytoplasmic vesicle, and membrane, which can matter when signal is compared across treatments or changing cell states. Following FGFR1ALPHA across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.\u003c\/p\u003e\u003ch2\u003eResearch Context\u003c\/h2\u003e\u003cp\u003eFGFR1ALPHA is commonly interpreted in the context of cancer, immunology, and developmental biology research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cell membrane, cytoplasm, and cytoplasmic vesicle, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.\u003c\/p\u003e\u003cp\u003eConsider these angles when interpreting target-level changes:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eapparent redistribution between cell membrane, cytoplasm, and cytoplasmic vesicle across matched conditions\u003c\/li\u003e\n\u003cli\u003echanges associated with proliferative state, oncogenic signaling, or treatment response\u003c\/li\u003e\n\u003cli\u003econtext differences tied to immune-cell state, activation, or lineage composition\u003c\/li\u003e\n\u003cli\u003estage-dependent patterns during differentiation, morphogenesis, or lineage commitment\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eVariant Considerations\u003c\/h2\u003e\u003cp\u003eIf your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for FGFR1ALPHA. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.\u003c\/p\u003e\u003cp\u003eStandardize sampling time, control choice, and downstream analysis thresholds so apparent differences in FGFR1ALPHA reflect biology rather than handling. When interpreting FGFR1ALPHA, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.\u003c\/p\u003e\u003cp\u003eFor multi-run studies, a shared reference condition can keep FGFR1ALPHA trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.\u003c\/p\u003e","brand":"Selleck Chemicals","offers":[{"title":"20 µl","offer_id":57577968795993,"sku":"F2732-20UL","price":199.0,"currency_code":"EUR","in_stock":true},{"title":"100 µl","offer_id":57577968828761,"sku":"F2732-100UL","price":489.0,"currency_code":"EUR","in_stock":true},{"title":"2 × 100 µl","offer_id":57577968861529,"sku":"F2732-2X100UL","price":729.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0923\/1011\/0553\/files\/F2732-IF.png?v=1773600653","url":"https:\/\/absource-diagnostics.myshopify.com\/products\/fgfr1alpha-antibody-sc-f2732","provider":"Absource Diagnostics","version":"1.0","type":"link"}